Novo Nordisk Gets EU Approval for Weight Loss Pill

The European Union has given the green light for Novo Nordisk’s new weight loss pill. This approval allows the drug to be marketed across the EU, potentially impacting the global market for obesity treatments. The decision follows a review of the drug’s efficacy and safety data.

Summarized from the sources above. Read the originals for the full story.